Secondary prevention of chronic PTSD by early and short-term administration of escitalopram: a prospective randomized, placebo-controlled, double-blind trial - Zohar J, Fostick L, Juven-Wetzler A, Kaplan Z, Shalev H, Schreiber G, Miroshnik N, Shalev AY, Stein DJ, Seedat S, Suliman S, Klein E.
OBJECTIVE: Prospective studies have not identified a viable pharmacologic strategy for secondary prevention of posttraumatic stress disorder (PTSD). The authors examined whether preventive intervention via early and short-term administration of a selective... (Source: SafetyLit)
Source: SafetyLit - July 22, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Brain Stimulation No Better Than Escitalopram for Depression
Patients receiving transcranial direct - current stimulation may experience more side effects (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 29, 2017 Category: Psychiatry Tags: Family Medicine, Nursing, Pharmacy, Psychiatry, Journal, Source Type: news
Not Just for Attention: Stop Teen Suicide
The subject of depression and suicide, especially in the case of children and teens, is a tremendous concern. Unfortunately, many cases go missed not necessarily because those surrounding these young people don’t care or pay enough attention to them, but more because they aren’t aware of what to look out for.
I am a suicide survivor. I also grew up with a suicidal mother and witnessed a peer successfully commit suicide, ironically, when I was in the emergency room beside her being treated for the same thing. I was saved, while her family still mourns for her.
These experiences, including the fact that my twelve-year-ol...
Source: Psych Central - March 29, 2017 Category: Psychiatry Authors: Chynna Laird Tags: Antidepressants Children and Teens Depression Medications Personal Stories Self-Esteem Stress Suicide Therapists Spill Treatment Anxiety Coping Skills Depression Mood Depressive Episode Major Depressive Disorder Monoamine Oxi Source Type: news
The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: a secondary analysis - Bausch P, Fangmeier T, Zobel I, Schoepf D, Drost S, Schnell K, Walter H, Berger M, Normann C, Schramm E.
Childhood maltreatment (CM) has been indicated as a predictor of a differential response to antidepressant treatment with psychotherapy compared to medication. In this secondary analysis, we investigated whether the presence of CM results in a differential... (Source: SafetyLit)
Source: SafetyLit - March 24, 2017 Category: Global & Universal Tags: Age: Adolescents Source Type: news
Lexapro (Escitalopram Oxalate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 20, 2017 Category: Drugs & Pharmacology Source Type: news
The 6 Medications You Should Never Take When Driving
It’s a given that safe driving needs concentration, alertness and an ability to react in a coordinated and timely fashion. But what may not occur to you is that the medications you’re taking can seriously impact all of these things. And it’s not just prescription medications, but over-the-counter products as well.
“While laws differ from state to state, you can be charged with a DUI if caught driving hazardously while taking prescription or OTC meds, even if your doctor wrote you that prescription,” adds C. Michael White, Pharm.D., FCP, FCCP, Professor and Head of the Department of Pharmacy Pr...
Source: Healthy Living - The Huffington Post - October 4, 2016 Category: Consumer Health News Source Type: news
Lexapro (escitalopram)
Title: Lexapro (escitalopram)Category: MedicationsCreated: 3/16/2003 12:00:00 AMLast Editorial Review: 8/15/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 15, 2016 Category: Drugs & Pharmacology Source Type: news
Fentanyl can cause serotonin syndrome
3.5 out of 5 stars
Serotonin Syndrome Induced by Fentanyl in a Child: Case Report. Robles LA. Clin Neuropharmacol 2015 Sept-Oct;38:206-8.
Abstract
When many clinicians think of serotonin syndrome (SS), they consider the usual suspects:
Selective Serotonin Uptake Inhibitors (SSRIs)
Citalopram
Fluoxetine
Sertraline
Escitalopram
Paroxetine
Serotonin-Norepinephrine Reuptake Inhibitors
Venlafaxine
Duloxetine
Antidepressants
Trazodone
Buspirone
Clomipramine
Aside from these common culprits, there are other commonly used drugs whose clear association with serotonin syndrome is less-often realized:
Fentanyl
Methadon...
Source: The Poison Review - July 8, 2016 Category: Toxicology Authors: Leon Gussow Tags: Medical fentanyl opioid serotonin syndrome Source Type: news
MOOD-HF supports lack of antidepressant efficacy in HF patients
Escitalopram influences neither depressive symptoms nor medical outcomes when compared with placebo in patients with heart failure and depression, show the MOOD-HF findings. (Source: MedWire News)
Source: MedWire News - June 28, 2016 Category: Consumer Health News Tags: Heart failure Source Type: news
Antidepressant Found Ineffective in Patients with Heart Failure (FREE)
By Joe Elia
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Escitalopram doesn't benefit depressed patients with heart failure, a JAMA study concludes.In Germany, researchers studied 372 patients … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 28, 2016 Category: Primary Care Source Type: news
Outcomes Similar for Escitalopram, Placebo in Depression + CHFOutcomes Similar for Escitalopram, Placebo in Depression + CHF
Although escitalopram was well tolerated, there were no differences between treatments "on the elevated mortality risk known to be associated with this comorbidity," note the MOOD-HF investigators. Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2016 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Escitalopram falls short in patients with heart failure and depression
Using escitalopram for patients with chronic heart failure and depression for more than 18 months neither significantly reduces mortality or hospitalization, nor improves depression, a study... (Source: Family Practice News)
Source: Family Practice News - June 28, 2016 Category: Primary Care Source Type: news
Antidepressant does not reduce hospitalization, death for HF patients with depression
Investigators have examined whether 24 months of treatment with the antidepressant escitalopram would improve mortality, illness, and mood in patients with chronic heart failure and depression. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 28, 2016 Category: Science Source Type: news
Antidepressant No Help to Heart Failure Patients: Study
TUESDAY, June 28, 2016 -- The antidepressant Lexapro may not help heart failure patients suffering from depression, German researchers report.
"Depression in heart failure may not be the same depression patients without heart failure get and who... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 28, 2016 Category: Journals (General) Source Type: news
Depression blood test could lead to personalised treatments
Conclusion
This study shows how a new blood test in development can help identify people with depression who are most and least likely to benefit from antidepressants.
While promising, the test is far from perfect. For example, it missed 39-43% of non-responders, meaning these people would continue to receive standard antidepressant treatment that is unlikely to work for them.
A large proportion of patients (22-38%) also fell into the "intermediate" group who were neither responders nor non-responders, so the test wasn't too useful here.
This means there is a significant proportion of people with depression ...
Source: NHS News Feed - June 7, 2016 Category: Consumer Health News Tags: Mental health Medication Source Type: news
